From the molecular perspective, polymorphisms in the polymerase E (POLE) gene are considered less harmful, resulting in an ultramutated profile that has an indolent course, whereas mutations of the p53 gene are associated with aggressive neoplasms that usually progress early [51]. Here, TP53 is linked to neoplasm.